spacer
home > pmps > winter 2017 > whats the outcome
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Whats the Outcome

The global delivery of healthcare has become more focused on medical outcomes, achieving results for patients and tying industry incentives to those results. As with any fundamental change in business structure, this is happening slowly and at different rates around the world. The case for change, however, is strong and compelling.

Population growth and rising incomes create further demand for access to healthcare; incidences of lifestyle-related health conditions like diabetes occur more frequently; and technological innovation continues to support increasing targeted disease and associated therapy identification, whether through genetic analysis or the discovery and commercialisation of large molecule therapies like biologics. The value of the ensuing biologics market is forecast to grow by 60%, rising to a value of $291 billion annually between 2014 and 2020.

With a stronger focus on outcomes, it will not be sufficient for biopharmaceutical innovators to only think about the elements of the solution like devices and connected services, for example shortly before market launch. A more rounded approach to creating value in healthcare delivery is needed. Tactically, this requires evaluating the system holistically (what results will we deliver, and why?) as well as each strategic element (how will the conclusion be achieved?) at least three years prior to the treatment being made available (before Phase 3). In doing so, outcome delivery and improvements become integrated parts of the answer. It is all part of providing end-to-end solutions that are focused on results, as delivering these will equal income in the future for the industry.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Bill Welch has over 25 years of contract design, development and manufacturing experience, primarily serving customers in the drug delivery, health technology and diagnostics markets. In his current capacity as Chief Technical Officer at Phillips-Medisize, he leads a global, over-500 person development, engineering, tooling, programme management and validation organisation with more than 75 concurrent schemes. Bill has been with Phillips-Medisize since 2002.
spacer
Bill Welch
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

CPhI China opens with analysis pointing to a surge in growth in 2019

Shanghai, 23rd May 2019: New analysis released ahead of CPhI & P-MEC China (#CPhIChina and #PMECChina) co-organized by Informa Markets, CCCMHPIE, and Shanghai Sinoexpo Informa Markets forecasts that China will continue to grow strongly through 2019/20, thanks in part to a marked improvement in its global reputation.
More info >>

White Papers

Advances in Aseptic Blow-Fill-Seal Processing of Pharmaceutical Liquids Improve Product Integrity and Patient Safety

Weiler Engineering, Inc

The latest improvements in aseptic blow-fill-seal technology are providing more streamlined automation of critical B/F/S processing areas, while limiting human intervention and effectively reducing airborne microbial bioburden and particulate levels, and enhancing sterility assurance and patient safety.
More info >>

 
Industry Events

SAPHEX 2019

23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement